TITLE

Cyclosporin for refractory ulcerative colitis

AUTHOR(S)
Loftus, C.G.; Loftus Jr., E.V.
PUB. DATE
February 2003
SOURCE
Gut;Feb2003, Vol. 52 Issue 2, p172
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Studies the clinical efficacy of cyclosporin on refractory ulcerative colitis (RUC). Comparison of effects between several dosages; Other treatment approaches for RUC; Role as a bridge to maintenance therapy with slowly acting agents such as azathioprine or 6-mercaptopurine; Toxicity associated with intravenous cyclosporin.
ACCESSION #
9704702

 

Related Articles

  • Azathioprine/ciclosporin.  // Reactions Weekly;12/2/2016, Vol. 1630 Issue 1, p29 

    An abstract of the article "The use of cyclosporin a in acute severe ulcerative colitis: Long-term outcomes" by L.M. Sharkey and others is presented.

  • Intravenous cyclosporine for refractory ulcerative colitis.  // American Family Physician;11/15/1994, Vol. 50 Issue 7, p1547 

    Focuses on research conducted by Lichtiger and colleagues on the effectiveness of intravenous cyclosporine in patients with severe ulcerative colitis published in the June 30, 1994 issue of the journal `New England Journal of Medicine.' Study of 20 patients with severe ulcerative colitis;...

  • Rapamycin decreases leukocyte migration in vivo and effectively reduces experimentally induced chronic colitis. Farkas, Stefan; Hornung, Matthias; Sattler, Christine; Guba, Markus; Steinbauer, Markus; Anthuber, Matthias; Herfarth, Hans; Schlitt, Hans J.; Geissler, Edward K. // International Journal of Colorectal Disease;Dec2006, Vol. 21 Issue 8, p747 

    Immunosuppressive calcineurin inhibitors, like cyclosporine (CsA), can be used for the clinical management of severe ulcerative colitis. However, patients treated with CsA are at a risk for developing kidney failure and may be more susceptible to colon cancer. Furthermore, severe neurotoxicity...

  • Does the Cyclosporine Still Have a Potential Role in the Treatment of Acute Severe Steroid-Refractory Ulcerative Colitis? Chang Soo Eun; Dong Soo Han // Gut & Liver;Sep2015, Vol. 9 Issue 5, p567 

    The article discusses a study which investigated the efficacy of cyclosporine and infliximab in 43 patients with severe steroid-refractory ulcerative colitis (UC) in a retrospective manner. It relates a justification for a prospective multicenter randomized clinical trial comparing the efficacy...

  • A Fatal Case of Diffuse Enteritis After Colectomy for Ulcerative Colitis: A Case Report and Review of the Literature. Feuerstein, Joseph D; Shah, Sveta; Najarian, Robert; Nagle, Deborah; Moss, Alan C // American Journal of Gastroenterology;Jul2014, Vol. 109 Issue 7, p1086 

    The article presents a case study of a 56-year-old woman with hematemesis and a 12-year history of left-sided ulcerative colitis (UC). It mentions that she could not respond to 5 days of intravenous (IV) steroids and salvage therapy with IV cyclosporine. She underwent proctocolectomy and her...

  • Controlled-release mesalamine maintains remission in ulcerative colitis.  // Modern Medicine;Jul95, Vol. 63 Issue 7, p52 

    Presents an abstract of the article titled `Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis,' by P. Miner, S. Hanauer, M. Robinson et al originally published in the February 1995 issue of `Digest of Diseases in Science.'

  • Soothe gut feelings. Munson, Marty; Yeykal, Teresa A. // Prevention;Aug94, Vol. 46 Issue 8, p36 

    States that new research suggests that `the patch' used by smokers may also be used to treat ulcerative colitis (UC). How it works is a bit of a mystery, but one theory suggests it may increase a natural anti-inflammatory hormone, called cortisol; Report in `New England Journal of Medicine,'...

  • Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Laharie, D. // Inflammatory Bowel Disease Monitor;2013, Vol. 13 Issue 3, p121 

    A review of the article "Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomized controlled trial," by D. Laharie and colleagues, which appeared in the 2012 issue of "Groupe d'Etudes Thérapeutiques des...

  • Decreasing colectomy rates for ulcerative colitis: a population-based time trend study. Kaplan, G. C. // Inflammatory Bowel Disease Monitor;2013, Vol. 13 Issue 3, p122 

    A review of the article "Decreasing colectomy rates for ulcerative colitis: A population-based time trend study," by G. G. Kaplan and colleagues, which appeared in the "American Journal of Gastroenterology" in the 2012 issue is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics